Cargando…
Mesenchymal Stromal Cells Suppress T-Cell-Mediated Delayed-Type Hypersensitivity via ALCAM-CD6 Interaction
Mounting evidence suggests mesenchymal stromal cells (MSCs) suppress CD4(+) T-cell activation, but whether MSCs directly regulate activation and expansion of allogeneic T cells has not been fully deciphered. Here, we identified that both human and murine MSCs constitutively express ALCAM, a cognate...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108723/ https://www.ncbi.nlm.nih.gov/pubmed/36972356 http://dx.doi.org/10.1093/stcltm/szad012 |
_version_ | 1785026899443974144 |
---|---|
author | Cho, WonKyung J Mittal, Sharad K Chauhan, Sunil K |
author_facet | Cho, WonKyung J Mittal, Sharad K Chauhan, Sunil K |
author_sort | Cho, WonKyung J |
collection | PubMed |
description | Mounting evidence suggests mesenchymal stromal cells (MSCs) suppress CD4(+) T-cell activation, but whether MSCs directly regulate activation and expansion of allogeneic T cells has not been fully deciphered. Here, we identified that both human and murine MSCs constitutively express ALCAM, a cognate ligand for CD6 receptors on T cells, and investigated its immunomodulatory function using in vivo and in vitro experiments. Our controlled coculture assays demonstrated that ALCAM-CD6 pathway is critical for MSCs to exert its suppressive function on early CD4(+)CD25(−) T-cell activation. Moreover, neutralizing ALCAM or CD6 results in the abrogation of MSC-mediated suppression of T-cell expansion. Using a murine model of delayed-type hypersensitivity response to alloantigen, we show that ALCAM-silenced MSCs lose the capacity to suppress the generation of alloreactive IFNγ-secreting T cells. Consequently, MSCs, following ALCAM knockdown, failed to prevent allosensitization and alloreactive T-cell-mediated tissue damage. |
format | Online Article Text |
id | pubmed-10108723 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-101087232023-04-18 Mesenchymal Stromal Cells Suppress T-Cell-Mediated Delayed-Type Hypersensitivity via ALCAM-CD6 Interaction Cho, WonKyung J Mittal, Sharad K Chauhan, Sunil K Stem Cells Transl Med Cell-Based Drug Development, Screening, and Toxicology Mounting evidence suggests mesenchymal stromal cells (MSCs) suppress CD4(+) T-cell activation, but whether MSCs directly regulate activation and expansion of allogeneic T cells has not been fully deciphered. Here, we identified that both human and murine MSCs constitutively express ALCAM, a cognate ligand for CD6 receptors on T cells, and investigated its immunomodulatory function using in vivo and in vitro experiments. Our controlled coculture assays demonstrated that ALCAM-CD6 pathway is critical for MSCs to exert its suppressive function on early CD4(+)CD25(−) T-cell activation. Moreover, neutralizing ALCAM or CD6 results in the abrogation of MSC-mediated suppression of T-cell expansion. Using a murine model of delayed-type hypersensitivity response to alloantigen, we show that ALCAM-silenced MSCs lose the capacity to suppress the generation of alloreactive IFNγ-secreting T cells. Consequently, MSCs, following ALCAM knockdown, failed to prevent allosensitization and alloreactive T-cell-mediated tissue damage. Oxford University Press 2023-04-17 /pmc/articles/PMC10108723/ /pubmed/36972356 http://dx.doi.org/10.1093/stcltm/szad012 Text en © The Author(s) 2023. Published by Oxford University Press. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Cell-Based Drug Development, Screening, and Toxicology Cho, WonKyung J Mittal, Sharad K Chauhan, Sunil K Mesenchymal Stromal Cells Suppress T-Cell-Mediated Delayed-Type Hypersensitivity via ALCAM-CD6 Interaction |
title | Mesenchymal Stromal Cells Suppress T-Cell-Mediated Delayed-Type Hypersensitivity via ALCAM-CD6 Interaction |
title_full | Mesenchymal Stromal Cells Suppress T-Cell-Mediated Delayed-Type Hypersensitivity via ALCAM-CD6 Interaction |
title_fullStr | Mesenchymal Stromal Cells Suppress T-Cell-Mediated Delayed-Type Hypersensitivity via ALCAM-CD6 Interaction |
title_full_unstemmed | Mesenchymal Stromal Cells Suppress T-Cell-Mediated Delayed-Type Hypersensitivity via ALCAM-CD6 Interaction |
title_short | Mesenchymal Stromal Cells Suppress T-Cell-Mediated Delayed-Type Hypersensitivity via ALCAM-CD6 Interaction |
title_sort | mesenchymal stromal cells suppress t-cell-mediated delayed-type hypersensitivity via alcam-cd6 interaction |
topic | Cell-Based Drug Development, Screening, and Toxicology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108723/ https://www.ncbi.nlm.nih.gov/pubmed/36972356 http://dx.doi.org/10.1093/stcltm/szad012 |
work_keys_str_mv | AT chowonkyungj mesenchymalstromalcellssuppresstcellmediateddelayedtypehypersensitivityviaalcamcd6interaction AT mittalsharadk mesenchymalstromalcellssuppresstcellmediateddelayedtypehypersensitivityviaalcamcd6interaction AT chauhansunilk mesenchymalstromalcellssuppresstcellmediateddelayedtypehypersensitivityviaalcamcd6interaction |